Last Updated 24 September 2021.
9 Vaccines Approved for Use in Mexico
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 100 countries
33 trials in 16 countries
Approval Source: nytimes.com
-
Moderna
mRNA-1273- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 72 countries
28 trials in 2 countries
Approval Source: reuters.com
-
CanSino
Ad5-nCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 9 countries
9 trials in 2 countries
Approval Source: reuters.com
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 71 countries
21 trials in 2 countries
Approval Source: coronavirus.gob.mx
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 66 countries
10 trials in 16 countries
Approval Source: gob.mx
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 122 countries
40 trials in 2 countries
Approval Source: coronavirus.gob.mx
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 9 countries
7 trials in 1 country
Approval Source: timesofindia.indiatimes.com
-
Sinopharm (Beijing)
BBIBP-CorV (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 64 countries
11 trials in 4 countries
Approval Source: gob.mx
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
19 trials in 2 countries
Approval Source: coronavirus.gob.mx
3 Vaccines in Clinical Trials in Mexico
-
Curevac
CVnCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
8 trials in 7 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 66 countries
10 trials in 16 countries
-
Laboratorio Avi-Mex
Recombinant NDV Vectored Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country